ESC 365 - Triglyceride glucose index, a novel marker of insulin resistance, predicts outcomes in patients with heart failure with preserved ejection fraction.

ESC Professional Premium Access

Triglyceride glucose index, a novel marker of insulin resistance, predicts outcomes in patients with heart failure with preserved ejection fraction.

Session: Further insights into inflammation, immunology, and insulin resistance in heart failure

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Speaker: Doctor K. Iwakura (Osaka, JP)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Katsuomi Iwakura

Sakurabashi Watanabe Advanced Healthcare Hospital, Osaka (Japan)

0 follower

7 more presentations in this session

Fibroblast activation protein-specific inhibitor imaging in heart failure

Speaker: Doctor S. Joshi (Edinburgh, GB)

Comparing indices of systemic inflammation and cardiac phenotype between hypertensive and non-hypertensive hypertrophic cardiomyopathy

Speaker: Doctor D. Zach (Heidelberg, DE)

Clonal hematopoiesis has prognostic value in dilated cardiomyopathy independent of age and clone size

Speaker: Mr M. Sikking (Maastricht, NL)

Sleep-disordered breathing is associated with fibrosis and impaired diastolic function

Speaker: Doctor M. Wester (Regensburg, DE)

Mitochondrial function is abnormal in circulating blood monocytes of patients with chronic heart failure

Speaker: Doctor D. Lanfear (Detroit, US)

Access the full session

Further insights into inflammation, immunology, and insulin resistance in heart failure

Speakers: Doctor K. Iwakura, Doctor S. Joshi, Doctor D. Zach, Mr M. Sikking, Doctor M. Wester...

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources